Pharmacological hypothesis: A recombinant probiotic for taming bacterial β‐glucuronidase in drug‐induced enteropathy

Advances in pharmacomicrobiomics have shed light on the pathophysiology of drug‐induced enteropathy associated with the therapeutic use of certain non‐steroidal anti‐inflammatory drugs, anticancer chemotherapies and immunosuppressants. The toxicity pathway results from the post‐glucuronidation relea...

Descripción completa

Detalles Bibliográficos
Autores principales: Jardou, Manon, Brossier, Clarisse, Guiyedi, Kenza, Faucher, Quentin, Lawson, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460963/
https://www.ncbi.nlm.nih.gov/pubmed/36082825
http://dx.doi.org/10.1002/prp2.998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460963/
https://www.ncbi.nlm.nih.gov/pubmed/36082825
http://dx.doi.org/10.1002/prp2.998

Ejemplares similares